Navigation

NEWS RELEASES

Search all of our news releases here.

Search
Generic filters

Try these: Jeff GalvinHIVFDAAmerican Gene Technologies

American Gene Technologies® Chief Medical Officer Honored by UCSF Endowment for HIV Dermatology and LGBTQ Health Research

Nov 1, 2022

Dr. Marcus Conant Named in UCSF’s Commitment to Pave Way for Next Generation of HIV Researchers American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, congratulates Dr. Marcus Conant and the University of California San Francisco (UCSF) Medical Center’s Department of Dermatology for… [Read More]

American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development

Sep 19, 2022

Dr. Wells’ promotion comes as the company’s HIV clinical trial progresses American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head of business development. Dr. Wells joined the company’s investor relations team in 2019.   “I… [Read More]

American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals

Jul 28, 2022

Beginning the analytic treatment interruption is a pivotal step to potentially demonstrating a gene therapy cure for HIV. American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point in its HIV cure clinical trial: it began withdrawing participants from their antiretroviral drugs earlier… [Read More]

American Gene Technologies® Appoints Dr. Jeff Boyle as Chief Science Officer

Jun 21, 2022

Dr. Boyle’s biotech and intellectual property expertise strengthen the team as the company proceeds to next phase of its HIV cure clinical trial American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post… [Read More]

angel

American Gene Technologies® Attracts Investment from Ride Wave Ventures

Apr 22, 2022

AGT™ welcomes additional support of its HIV Cure clinical trial and broad gene therapy development platform American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, announced today that angel investor Ride Wave Ventures has made its first investment in the company.   Ride… [Read More]

American Gene Technologies® Launches “The Cure Chronicles” Video Series

Mar 30, 2022

“The Cure Chronicles” presents thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working toward ending the HIV epidemic. American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, has launched a video series showcasing compelling HIV community conversations: The… [Read More]

American Gene Technologies® Applauds the State of Maryland for Supporting Biotech Investment

Mar 2, 2022

Maryland’s Biotechnology Investment Incentive Tax Credit (BIITC) program generates multiple benefits for the state American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, thanks the State of Maryland for its commitment to supporting biotech research through initiatives like the Biotechnology Investment Incentive Tax… [Read More]

American Gene Technologies® Advances Closer to Demonstrating a Potential Cure for HIV

Feb 24, 2022

HIV cure clinical trial data shows safety and efficacy of AGT™ gene therapy treatment, the company will begin withdrawing participants from antiretrovirals in Q2 to test potential functional cure American Gene Technologies (AGT), a clinical-stage biotechnology company working to cure HIV, announced that the independent… [Read More]

American Gene Technologies® HIV Clinical Trial Shows Blood Markers of Efficacy in Two More Patients

Feb 2, 2022

Data from a Total of Five Patients Demonstrates Critical Markers of the Company’s HIV Cure Gene & Cell Therapy American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, announced that it has reached another important milestone for its HIV cure program. Five participants were… [Read More]

American Gene Technologies® Appoints Dr. Drew Palin as Business and Strategy Advisor to the CEO

Jan 5, 2022

Dr. Palin’s expertise in the intersection of business and technology strengthens AGT™ capability to bring patient solutions to the market. American Gene Technologies (AGT) announces the appointment of Dr. Drew Palin as business and strategy advisor to Jeff Galvin, CEO.   “I am excited to have… [Read More]

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media